FDA
FDA Articles
Amgen is slowly getting closer to an FDA final decision for its first-of-a-kind cancer therapy, talimogene laherparepvec (T-Vec).
Published:
ThinkstockThe U.S. Food and Drug Administration (FDA) issued a warning that hepatitis C treatments, Viekira Pak and Technivie, can cause serious liver injury mostly in patients with underlying...
Published:
Last Updated:
ThinkstockGNC Holdings Inc. (NYSE: GNC) is getting its turn in the negative news mill over the quality and legality of supplement sales. As you might have guessed, it is not in a positive manner....
Published:
Merrimack Pharmaceuticals saw its shares halted for "news pending" due to an approval from the FDA.
Published:
Corbus Pharmaceuticals announced that the FDA has designated as a Fast Track development program and granted Orphan Drug Designation to the its investigational new drug Resunab.
Published:
In April of this year, a nonprofit organization called U.S. Right to Know requested an investigation into the use of the word "diet" as used in product advertising.
Published:
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of October and added some color.
Published:
Shares of Evoke Pharma rose in the market on Tuesday in the wake of solid draft guidance for its Phase 3 study.
Published:
GW Pharmaceuticals is making great strides in the field of medicine with its most recent trial of Cannabidiol in patients with schizophrenia.
Published:
Over the past week, a few biotech companies made absolutely massive runs with at least 25% gains.
Published:
ThinkstockAbbVie Inc. (NYSE: ABBV) has continued to push forward over the past year and shares are actually up 7.3% in the past 52-weeks despite the markets pulling back in August. Late Thursday, the...
Published:
Last Updated:
When investors see a drop of almost 80% in a share price, the question of long-term viability is almost impossible to ignore.
Published:
24/7 Wall St. wants to see if Tuesday's move in Nanosphere after an FDA OK is sustainable.
Published:
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of September and added some color.
Published:
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of September and added some color.
Published: